SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-326207
Filing Date
2012-07-31
Accepted
2012-07-31 17:25:55
Documents
4
Period of Report
2012-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d388571d8k.htm 8-K 21407
2 ENGLISH TRANSLATION OF PRESS RELEASE d388571dex991.htm EX-99.1 54410
3 GRAPHIC g388571img001.jpg GRAPHIC 2507
4 GRAPHIC g388571img002.jpg GRAPHIC 1727
  Complete submission text file 0001193125-12-326207.txt   83121
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 12997775
SIC: 2834 Pharmaceutical Preparations